Cell death mechanisms of the anti-cancer drug etoposide on human cardiomyocytes isolated from pluripotent stem cells
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0738
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cell death mechanisms of the anti-cancer drug etoposide on human cardiomyocytes isolated from pluripotent stem cells ; volume:92 ; number:4 ; day:3 ; month:2 ; year:2018 ; pages:1507-1524 ; date:4.2018
Archives of toxicology ; 92, Heft 4 (3.2.2018), 1507-1524, 4.2018
- Creator
-
Nemade, Harshal
- Contributor
-
Chaudhari, Umesh
Acharya, Aviseka
Hescheler, Jürgen
Hengstler, Jan G.
Papadopoulos, Symeon
Sachinidis, Agapios
SpringerLink (Online service)
- DOI
-
10.1007/s00204-018-2170-7
- URN
-
urn:nbn:de:101:1-2018060923381327370146
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Nemade, Harshal
- Chaudhari, Umesh
- Acharya, Aviseka
- Hescheler, Jürgen
- Hengstler, Jan G.
- Papadopoulos, Symeon
- Sachinidis, Agapios
- SpringerLink (Online service)
Other Objects (12)
MicroRNAs as early toxicity signatures of doxorubicin in human-induced pluripotent stem cell-derived cardiomyocytes
Control mechanisms of carcinogenesis
Functional cardiotoxicity assessment of cosmetic compounds using human-induced pluripotent stem cell-derived cardiomyocytes
From bisphenol A to bisphenol F and a ban of mustard due to chronic low-dose exposures?
Essential components of methods papers
Conflict of interest Statements : current dilemma and a possible way forward
Evaluation of etoposide-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes
Highlight report : towards the replacement of in vivo repeated dose systemic toxicity testing
Characterization of pluripotent stem cell derived cardiomyocytes
Characterization of pluripotent stem cell-derived cardiomyocytes
Transcriptome-based prediction of drugs, inhibiting cardiomyogenesis in human induced pluripotent stem cells
Toxikologie - Wurzeln und Wandel
MicroRNAs as early toxicity signatures of doxorubicin in human-induced pluripotent stem cell-derived cardiomyocytes
Control mechanisms of carcinogenesis
Functional cardiotoxicity assessment of cosmetic compounds using human-induced pluripotent stem cell-derived cardiomyocytes
From bisphenol A to bisphenol F and a ban of mustard due to chronic low-dose exposures?
Essential components of methods papers
Conflict of interest Statements : current dilemma and a possible way forward
Evaluation of etoposide-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes
Highlight report : towards the replacement of in vivo repeated dose systemic toxicity testing
Characterization of pluripotent stem cell derived cardiomyocytes
Characterization of pluripotent stem cell-derived cardiomyocytes
Transcriptome-based prediction of drugs, inhibiting cardiomyogenesis in human induced pluripotent stem cells
Toxikologie - Wurzeln und Wandel
MicroRNAs as early toxicity signatures of doxorubicin in human-induced pluripotent stem cell-derived cardiomyocytes
Control mechanisms of carcinogenesis
Functional cardiotoxicity assessment of cosmetic compounds using human-induced pluripotent stem cell-derived cardiomyocytes
From bisphenol A to bisphenol F and a ban of mustard due to chronic low-dose exposures?
Essential components of methods papers
Conflict of interest Statements : current dilemma and a possible way forward
Evaluation of etoposide-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes
Highlight report : towards the replacement of in vivo repeated dose systemic toxicity testing
Characterization of pluripotent stem cell derived cardiomyocytes
Characterization of pluripotent stem cell-derived cardiomyocytes
Transcriptome-based prediction of drugs, inhibiting cardiomyogenesis in human induced pluripotent stem cells